In agreement with the previous result, the plasma BST2 levels still showed a significant increase in CRC patients as compared to the controls in this independent sample set (2.35 ± 0.13 ng/mL versus 1.04 ± 0.03 ng/mL, p < 0.01, independent t-test; Figure 1(b), left panel). The gene discussed is BST2; the disease is colorectal carcinoma.